Open Medicine Foundation®
Leading research. Delivering hope.
ME/CFS and related chronic complex diseases

News

National DNA Day

Happy #OMFScienceWednesday, and happy National DNA Day! This year’s National DNA Day is a very special one, as it marks the 15th anniversary of the completion of the Human Genome Project. This is a great opportunity for students, teachers, and the public to learn more about how advances in genetics and genomics have changed people’s…

Read More

The hunt for elusive pathogens in ME/CFS

Do infections lead to lasting changes in immune or metabolic function that lead to symptoms, or is the pathogen still present?   This #OMFScienceWednesday, OMF discusses recently funded research into addressing this central question in ME/CFS. Do infections lead to lasting changes in immune or metabolic function that lead to symptoms, is the pathogen still present,…

Read More

RBC shape, RBC deformability

Many of you have been asking questions about our red blood cell research. For this #OMFScienceWednesday, we examine the difference between RBC shape and RBC deformability, and how they relate to blood flow. RBC shape You may have seen an image of a red blood cell (RBC) in the past: it is a small, pink…

Read More

The ‘omes’

Do you know your ‘omes’? For this #OMFScienceWednesday, we look at the ‘omes’ studied in biomedical research, and why we are funding projects to study them in ME/CFS. Genome: The genome refers to all of the DNA in a living thing.  The DNA is organized into genes that code for proteins that have specific jobs…

Read More

OMF-funded research: red blood cell deformability in ME/CFS

On this #OMFScienceWednesday, we present a new project that we are funding that will evaluate the ‘deformability’ of red blood cells as a potential biomarker for ME/CFS. Red blood cells (RBCs) are the most common cells in the blood. Their main role is to transport oxygen and carbon dioxide in the blood, and this role…

Read More

OMF-funded research: a metabolic ‘trap’ hypothesis for ME/CFS

On this #OMFScienceWednesday we highlight a new project that OMF is funding, which proposes a new metabolic ‘trap’ hypothesis for ME/CFS. This project is just getting started under the direction of Dr. Robert Phair, Chief Science Officer of Integrative Bioinformatics, Inc., an expert in computational modelling of biological processes. Dr. Phair has been collaborating with…

Read More

OMF Newsletter – March 2018

Linda Tannenbaum Named 2017 Advocate of the Year There’s an Angel Among Us – Linda Tannenbaum Is Offering Genuine Hope to ME/CFS Patients (Shared from ProHealth) ProHealth is proud to name Linda Tannenbaum, founder of Open Medicine Foundation, as ProHealth’s 2017 ME/CFS Advocate of the Year. ProHealth founder, Rich Carson said, “Linda is a bottomless pit of compassion and…

Read More

OMF-funded research: diagnostic and drug-screening technology

On this #OMFScienceWednesday we continue our series on research projects that OMF is funding all over the world, with a look at efforts to develop diagnostic and drug-screening technology for ME/CFS. This project is ongoing at the ME/CFS Collaborative Research Center at Stanford under the direction of Dr. Ron Davis. We are hopeful that the…

Read More

OMF-funded research: T cells and molecular immunology

It’s #OMFScienceWednesday! For the next few weeks, we will be describing the research projects that OMF is funding all over the world. The first project is about T cells and molecular immunology of ME/CFS, at the ME/CFS Collaborative Research Center at Stanford under the direction of Dr. Ron Davis. This project is a collaboration with…

Read More

What do T cells and B cells do?

On this #OMFScienceWednesday, we look at two cell types in our immune system that have been particularly interesting for ME/CFS research lately: T cells and B cells. Both of these cell types are important for defending us against infections, but they do so in different ways: B cells produce antibodies to ‘capture’ invading germs. Sometimes…

Read More